MOPA -- Media, All-In-One Agency, Blockchain Development
Social Media/Email
  • WORK
  • NEWS
  • SERVICE
  • CONTACT

Dermatology Leader Galderma Expands Manufacturing and Innovation Footprint in Asia Pacific

10/18/2022

0 Comments

 
Picture
Source: Galderma

Oct.18.2022, Singapore ------ Galderma, the leading dermatology company in the world, today announced its intention to expand its manufacturing and innovation footprint in the Asia-Pacific region, with support from the Singapore Economic Development Board. Reaffirming its bold ambition, Galderma intends to explore opportunities to build a fifth manufacturing plant with a high degree of digitalization and automation in Singapore in response to growing consumer demand and to support long-term sustainable growth over the coming years.
Picture
Left: Mr Tan Kong Hwee, Executive Vice President, Economic Development Board; right: Flemming Ørnskov, M.D., MPH, Chief Executive Officer, Galderma
​The announcement comes as part of Galderma’s strategic manufacturing roadmap, aligned with the company’s unique Integrated Dermatology Strategy. Following a record 2021 performance, Galderma has demonstrated strong commercial and financial performance in the first half of 2022, with continued strong growth across product categories. In particular, Dermo-cosmetics has grown by 31% year-on-year on a constant currency basis, fueled by the strong performance of Cetaphil® driven by e-commerce and launches in China and the rest of Asia.
“Our goal is to support our strong growth trajectory in the long-term with a new manufacturing plant that will significantly increase our capacity to serve consumers with premium brands from our differentiated Dermo-cosmetics portfolio across geographies, and primarily throughout our key markets in Asia-Pacific. We sincerely thank the Economic Development Board of Singapore for its support, and we look forward to further collaboration to bring this exciting project to life”, Flemming  Ørnskov, M.D., MPH, Chief Executive Officer, Galderma.
​With its premiumization strategy and broad channel exposure, Galderma is well positioned to capitalize on growing consumer demand across Asia-Pacific, where the compelling dermatology market has remained on a consistent growth trajectory, with robust demand for premium science-based products. Galderma’s new manufacturing plant in Singapore is expected to increase the company’s total capacity for Dermo-cosmetics premium brand production by up to 350 million units a year, in line with anticipated growth in the region.
“We welcome Galderma's expansion in Singapore, driven by the need to meet growing demand and sophistication of consumers in Asia. This adds to the growing number of consumer healthcare companies that use Singapore as a hub for innovation. We are also pleased that Galderma's first Dermo-cosmetics manufacturing plant in Asia will be landing in Singapore, as it will leverage and contribute to Singapore's advanced manufacturing capabilities. There will be many exciting innovation and manufacturing job opportunities that Galderma will create with this investment”, Mr Tan Kong Hwee, Executive Vice President, Economic Development Board
​Galderma already benefits from a well-established presence in Singapore, which is not only a key market for Galderma’s innovative portfolio of cutting-edge brands and services, but also serves as its Asia-Pacific regional hub.
Picture
About Galderma

Galderma is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that spans the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermo-cosmetics and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we’re in shapes our lives, we are advancing dermatology for every skin story.

For more information: www.galderma.com
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    News WorldWide

    MOPA
    ​Media, 
    All-In-One Agency, Blockchain Development

    Online Service

    ​Media
    ​Branding
    ​Celebrity Content
    ​Cultural Exchange
    Digital Marketing
    Public Relations
    Makeup
    Blockchain Project

    Our location:
    ​
    Auckland, ​New Zealand​
    Brisbane, Australia
    Shanghai, China
    Singapore


    Email:  info@mopa1.com
    Picture
     

    Archives

    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    April 2021
    March 2021
    February 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    August 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    October 2016
    November 2014
    August 2014
    July 2014
    April 2014
    March 2014
    February 2014
    October 2013
    September 2013
    June 2013

    Categories

    All
    Asia Pacific
    Australia
    Brazil
    Chile
    China
    Cuba
    Japan
    Latin America
    Mexico
    Singapore
    United States
    Venezuela
    Vietnam

    RSS Feed

Powered by Create your own unique website with customizable templates.